Retracted: Dapagliflozin Improves Diabetic Cardiomyopathy by Modulating the Akt/mTOR Signaling Pathway

Detalles Bibliográficos
Autor principal: International, BioMed Research
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307049/
https://www.ncbi.nlm.nih.gov/pubmed/37388370
http://dx.doi.org/10.1155/2023/9765065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307049/
https://www.ncbi.nlm.nih.gov/pubmed/37388370
http://dx.doi.org/10.1155/2023/9765065

Ejemplares similares